Log in
Enquire now
‌

US Patent 7682801 Dual path immunoassay device

Patent 7682801 was granted and assigned to Chembio Diagnostic Systems, Inc. on March, 2010 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
Chembio Diagnostic Systems, Inc.
Chembio Diagnostic Systems, Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
76828010
Patent Inventor Names
Javanbakhsh Esfandiari0
Date of Patent
March 23, 2010
0
Patent Application Number
116835400
Date Filed
March 8, 2007
0
Patent Citations Received
‌
US Patent 12111312 Coronavirus IgG/IgM multiplexed dual path immunoassay device
0
Patent Primary Examiner
‌
Bao-Thuy L. Nguyen
0
Patent abstract

The systems of the invention include test cells with a first sorbent material defining a first flow path for a solution, a second sorbent material defining a second flow path distinct from the first flow path for a sample, and a test line or test site with immobilized antigens or antibodies or other ligand binding molecules such as aptamers, nucleic acids, etc. located at the junction of the first and second sorbent materials. The first and second sorbent strips touch each other at the test site location.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7682801 Dual path immunoassay device

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.